Ascendis Pharma A/S - ASND
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2026
· Q1 2026
Value (USD)
Total reported value ($000)
$282.7M
QoQ value delta ($000)
-$12.56B
(-97.8%)
Implied price effect (QoQ)
+16.6%
Shares
Total shares
1,060,775
QoQ shares delta
-55,136,841
(-98.11%)
Total shares held by funds (by quarter)
Market chart (ASND)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2026)
Top 25 only
Full list
Partial Q2 2026 data: 11 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| STATE STREET CORP | 137,085 | 513,969 | 0.0% |
| Frazier Life Sciences Management, L.P. | 60,053 | 225,155 | 1.31% |
| Neuberger Berman Group LLC | 38,062 | 142,705 | 0.03% |
| ODDO BHF ASSET MANAGEMENT SAS | 34,315 | 128,657 | 1.59% |
| Quadrature Capital Ltd | 10,894 | 40,845 | 0.09% |
| Brooklyn Investment Group | 931 | 4,072 | 0.03% |
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | 693 | 2,600 | 0.01% |
| CWM, LLC | 308 | 1,347 | 0.0% |
| DEARBORN PARTNERS LLC | 297 | 1,300 | 0.02% |
| E Fund Management (Hong Kong) Co., Ltd. | 22 | 84 | 0.01% |
| Ninepoint Partners LP | 6 | 26 | 0.0% |
| IFP Advisors, Inc | 3 | 14 | 0.0% |
| HUNTINGTON NATIONAL BANK | 0 | 1 | 0.0% |